Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/23811
Full metadata record
DC FieldValueLanguage
dc.contributor.authorElisaf, M. S.en
dc.contributor.authorTsianos, E.en
dc.contributor.authorMavridis, A.en
dc.contributor.authorDardamanis, M.en
dc.contributor.authorPappas, M.en
dc.contributor.authorSiamopoulos, K. C.en
dc.date.accessioned2015-11-24T19:36:07Z-
dc.date.available2015-11-24T19:36:07Z-
dc.identifier.issn0931-0509-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/23811-
dc.rightsDefault Licence-
dc.subjectAdolescenten
dc.subjectAdulten
dc.subjectAgeden
dc.subjectBiological Markersen
dc.subjectFemaleen
dc.subjectHepacivirus/*immunologyen
dc.subjectHepatitis Antibodies/*blooden
dc.subjectHepatitis B/transmissionen
dc.subjectHepatitis B Antibodies/blooden
dc.subjectHepatitis B Surface Antigens/blooden
dc.subjectHepatitis C/transmissionen
dc.subjectHepatitis C Antibodiesen
dc.subjectHumansen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectRenal Dialysis/*adverse effectsen
dc.titleAntibodies against hepatitis C virus (anti-HCV) in haemodialysis patients: association with hepatitis B serological markersen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/1717891-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate1991-
heal.abstractHepatitis C virus (HCV) seems to be the main causative agent of the parenterally transmitted non-A, non-B hepatitis and the detection of anti-HCV may be a marker of ongoing infection with this virus. This study was undertaken to determine the frequency of anti-HCV in 51 haemodialysis patients of our renal unit. In addition association of these antibodies to sex, history of blood transfusions, and duration on haemodialysis, as well as to serological markers of hepatitis B virus infection, was applied. Enzyme-linked immunosorbent assay (ELISA), were used for the detection of all serological markers. Nine of the 51 (17.6%) haemodialysis patients had anti-HCV. The presence of anti-HCV was related to male sex. Although seropositive patients were transfused more often than seronegatives, this difference is not statistically significant. The presence of anti-HCV was associated with the duration of haemodialysis. The majority of anti-HCV patients had serological markers of previous HBV infection, in contrast to seronegative patients.en
heal.journalNameNephrol Dial Transplanten
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons